Murphy SA - Search Results

1

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators; Steen DL. O'Donoghue ML, et al. Among authors: murphy sa. JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. JAMA. 2014. PMID: 25173516 Clinical Trial.

2

Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.

Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Gibson CM, et al. Am Heart J. 1999 Jun;137(6):1179-84. doi: 10.1016/s0002-8703(99)70380-7. Am Heart J. 1999. PMID: 10347349

3

Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.

Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, Marble SJ, Giugliano RP, Antman EM, Cannon CP, Braunwald E. Gibson CM, et al. J Am Coll Cardiol. 1999 Nov 1;34(5):1403-12. doi: 10.1016/s0735-1097(99)00397-6. J Am Coll Cardiol. 1999. PMID: 10551685

4

Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).

Llevadot J, Giugliano RP, McCabe CH, Cannon CP, Antman EM, Murphy S, Gibson CM. Llevadot J, et al. Am J Cardiol. 2000 Jun 15;85(12):1409-13. doi: 10.1016/s0002-9149(00)00786-4. Am J Cardiol. 2000. PMID: 10856384

5

Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.

Srinivas VS, Cannon CP, Gibson CM, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E, Mueller HS. Srinivas VS, et al. Am Heart J. 2001 Jul;142(1):29-36. doi: 10.1067/mhj.2001.116068. Am Heart J. 2001. PMID: 11431653 Clinical Trial.

6

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Sabatine MS, et al. Among authors: murphy sa. Circulation. 2002 Apr 16;105(15):1760-3. doi: 10.1161/01.cir.0000015464.18023.0a. Circulation. 2002. PMID: 11956114

7

Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery.

Gibson CM, Chen M, Angeja BG, Murphy SA, Marble SJ, Barron HV, Cannon CP; TIMI Study Group. Gibson CM, et al. Among authors: murphy sa. J Thromb Thrombolysis. 2002 Feb;13(1):9-12. doi: 10.1023/a:1015355722670. J Thromb Thrombolysis. 2002. PMID: 11994554 Clinical Trial.

8

Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.

Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E; TIMI Study Group. Gibson CM, et al. Among authors: murphy sa. Circulation. 2002 Apr 23;105(16):1909-13. doi: 10.1161/01.cir.0000014683.52177.b5. Circulation. 2002. PMID: 11997276 Clinical Trial.

9

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.

Antman EM, Cooper HA, Gibson CM, de Lemos JA, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Van de Werf F, Braunwald E; Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Antman EM, et al. Eur Heart J. 2002 Jun;23(12):928-33. doi: 10.1053/euhj.2001.2964. Eur Heart J. 2002. PMID: 12069446

10

Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I).

Murphy SA, Gibson CM, Van de Werf F, McCabe CH, Cannon CP. Murphy SA, et al. Am J Cardiol. 2002 Jul 1;90(1):51-4. doi: 10.1016/s0002-9149(02)02387-1. Am J Cardiol. 2002. PMID: 12088781 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

671 results

Search Page

Filters